About the Partner

npj Breast Cancer is a part of the Nature Partner Journals series and is published by Springer Nature in partnership with the Breast Cancer Research Foundation (BCRF).

The Breast Cancer Research Foundation (BCRF) is an independent, nonprofit organization committed to achieving prevention and a cure for breast cancer. BCRF provides critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. It has funded basic research on genetic susceptibility to breast cancer, breast cancer stem cells, trastuzumab (Herceptin), anti-angiogenesis treatment with bevacizumab (Avastin), MRI imaging, aromatase inhibitors, tamoxifen; and also clinical trials of new treatments with the Translational Breast Cancer Research Consortium.

BCRF is recognized as one of the most financially efficient nonprofits in the country. They are the highest rated breast cancer organization in the U.S. with an A+ rating from Charity Watch and 4 out of 4 stars from Charity Navigator.

Since its foundation in 1993 by Evelyn H. Lauder, BCRF has raised more than half a billion dollars to support clinical and translational research at medical institutions worldwide. It currently funds over 200 researchers in 6 continents and 13 countries. In 2014-2015, BCRF awarded $58.6 million in annual grants to 222 scientists from top universities and medical institutions around the globe. In addition, $11.6 million has been committed to the international Founder’s Fund project focused on metastasis. Through a unique and streamlined grants program, BCRF seeks out the brightest minds in science and medicine and gives them the necessary resources to pursue their best ideas. As a result, researchers are able to make discoveries and design new approaches to address all aspects of breast cancer-and do so in record time.

The BCRF Mission

To prevent and cure breast cancer by advancing the world's most promising research.